According to NewAmsterdam Pharma Company's latest financial reports the company's current EPS (TTM) is -$1.03. In 2022 the company made an earnings per share (EPS) of -$1.03 a decrease over its 2021 EPS that were of -$0.40.
Year | EPS | Change |
---|---|---|
2022 | -$1.03 | 158.9% |
2021 | -$0.40 | 358.03% |
2020 | -$0.08670 |